Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects

Clinical trial NCT03399214 · COMPLETED

Trial details

NCT number: NCT03399214
Sponsor: MegaPro Biomedical Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Magnetic Resonance Imaging

Start date: 2018-04-01
Primary completion: 2018-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.